MedTrace Logo

JAVLOR® Online Non-Interventional Trial

NCT01103544 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2015-05-13

No results posted yet for this study

Summary

Documentation of data concerning tolerability and efficacy of the intravenous treatment with vinflunine performed under daily routine conditions in Germany. The trial focusses on tolerability including the assessment of the usage of anti-emetic and anti-obstipative concomitant treatment as well as on the efficacy of the treatment.

Conditions

  • Transitional Cell Carcinoma

Sponsors & Collaborators

  • DocCheck Medical Services GmbH

    collaborator UNKNOWN

  • Pierre Fabre Pharma GmbH

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2011-09-30
Completion
2013-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01103544 on ClinicalTrials.gov